Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 May;33(5):894-900.
doi: 10.1007/s00134-007-0580-8. Epub 2007 Mar 7.

Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not?

T C Jansen  1 , E J O Kompanje  2 , C Druml  3 , D K Menon  4 , C J Wiedermann  5 , J Bakker  1
Affiliations

Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not?

T C Jansen et al. Intensive Care Med. 2007 May.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow-chart of the process of deferred consent in enrolled patients in the “Early Lactate-Directed Therapy on the ICU” study (February–December 2006)
Fig. 2
Fig. 2
Survey among investigators active in the field of traumatic brain injury. Within which time period should proxy deferred consent be obtained or information provided? (n = 77) [14]
See this image and copyright information in PMC

Comment in

References

    1. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862–871. doi: 10.1001/jama.288.7.862. - DOI - PubMed
    1. Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, Brampton W, Williams D, Young D, Rowan K. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet. 2005;366:472–477. doi: 10.1016/S0140-6736(05)67061-4. - DOI - PubMed
    1. Marshall LF, Maas AI, Marshall SB, Bricolo A, Fearnside M, Iannotti F, Klauber MR, Lagarrigue J, Lobato R, Persson L, Pickard JD, Piek J, Servadei F, Wellis GN, Morris GF, Means ED, Musch B. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg. 1998;89:519–525. doi: 10.3171/jns.1998.89.4.0519. - DOI - PubMed
    1. Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA. 1996;276:538–543. doi: 10.1001/jama.1996.03540070034027. - DOI - PubMed
    1. Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med. 2002;30:1686–1692. doi: 10.1097/00003246-200208000-00002. - DOI - PubMed